Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Metformin and Vaccine Response in Older Adults
Authors not listed
The University of Texas Health Science Center at San Antonio · 2019
Abstract
To determine whether metformin (MET) can improve the immune response to the pneumococcal conjugate vaccine (PCV-13) in older adults.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2019). Metformin and Vaccine Response in Older Adults. <em>The University of Texas Health Science Center at San Antonio</em>. https://clinicaltrials.gov/study/NCT03713801
Vancouver
Anonymous. Metformin and Vaccine Response in Older Adults. The University of Texas Health Science Center at San Antonio. 2019.
BibTeX
@misc{anon2019Metfor,
title = {Metformin and Vaccine Response in Older Adults},
author = {Anonymous},
journal = {The University of Texas Health Science Center at San Antonio},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in aging 2025
Open access · OA
METFORMIN TO TARGET FRAILTY IN OLDER ADULTS
New England Journal of Medicine 2024
Preprint · OA
Frailty in Older Adults
Innovation in aging 2025
Open access · OA
A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance
Oregon Health and Science University 2024
Open access · US-GOV
Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults
International Journal of Molecular Sciences 2024
Open access · CC-BY
MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program
Frontiers in aging
Open access · OA